Suppr超能文献

聚丙烯与硅胶Ahmed青光眼引流阀的比较。

Comparison of polypropylene and silicone Ahmed Glaucoma Valves.

作者信息

Ishida Kyoko, Netland Peter A, Costa Vital P, Shiroma Lineu, Khan Baseer, Ahmed Iqbal Ike K

机构信息

Hamilton Eye Institute, Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.

出版信息

Ophthalmology. 2006 Aug;113(8):1320-6. doi: 10.1016/j.ophtha.2006.04.020.

Abstract

PURPOSE

To evaluate and compare the clinical outcomes after implantation of the silicone plate and the polypropylene plate Ahmed Glaucoma Valves.

DESIGN

Prospective, multicenter, comparative series.

METHODS

A total of 132 patients with uncontrolled glaucoma were treated with either the silicone or polypropylene Ahmed Glaucoma Valve implant.

MAIN OUTCOME MEASURES

Success was defined according to 2 criteria: (1) intraocular pressure (IOP) of 6 mmHg or more or 21 mmHg or less, and (2) IOP reduction of at least 30% relative to preoperative values. Eyes requiring further glaucoma surgery, including cyclophotocoagulation, or showing loss of light perception were classified as failures.

RESULTS

Average follow-up was 12.8 months (range, 6-30 months) for the silicone plate group and 14.5 months (range, 6-30 months) for the polypropylene plate group (P = 0.063). At the last follow-up examination, the mean IOP was 13.8+/-3.9 mmHg and 17.3+/-6.5 mmHg (P<0.0001) and the mean number of antiglaucoma medications was 1.9+/-1.3 and 2.1+/-1.4 (P = 0.48) in the silicone plate and polypropylene plate groups, respectively. The life-table success rates for the silicone plate and polypropylene plate groups were 94.2% and 83.2% at 12 months and 82.4% and 56.7% at 24 months by definition 1, respectively (P = 0.035). When an IOP reduction of at least 30% was used for success criterion (definition 2), probabilities of success were 89.5% and 71.7% at 12 months and 78.3% and 68.5% at 24 months in the silicone and the polypropylene plate groups, respectively (P = 0.012). Visual outcomes were comparable between the 2 groups. However, complications including Tenon's cyst were observed more frequently in the polypropylene plate than in the silicone plate group (P<0.05).

CONCLUSIONS

The silicone Ahmed Glaucoma Valve (model FP7) showed improved IOP reduction compared with the polypropylene (model S2) implant. Differences observed in mean IOP, success rate, and complications suggest that plate material may influence clinical outcome.

摘要

目的

评估并比较硅酮板和聚丙烯板Ahmed青光眼阀植入术后的临床效果。

设计

前瞻性、多中心、比较性系列研究。

方法

共132例青光眼控制不佳的患者接受了硅酮或聚丙烯Ahmed青光眼阀植入治疗。

主要观察指标

成功的定义依据两个标准:(1)眼压(IOP)为6 mmHg或更高或21 mmHg或更低,以及(2)眼压相对于术前值降低至少30%。需要进一步进行青光眼手术(包括睫状体光凝术)或出现光感丧失的眼睛被归类为失败。

结果

硅酮板组的平均随访时间为12.8个月(范围6 - 30个月),聚丙烯板组为14.5个月(范围6 - 30个月)(P = 0.063)。在最后一次随访检查时,硅酮板组和聚丙烯板组的平均眼压分别为13.8±3.9 mmHg和17.3±6.5 mmHg(P<0.0001),抗青光眼药物的平均使用数量分别为1.9±1.3和2.1±1.4(P = 0.48)。根据定义1,硅酮板组和聚丙烯板组在12个月时的生命表成功率分别为94.2%和83.2%,在24个月时分别为82.4%和56.7%(P = 0.035)。当将眼压降低至少30%用作成功标准(定义2)时,硅酮板组和聚丙烯板组在12个月时的成功概率分别为89.5%和71.7%,在24个月时分别为78.3%和68.5%(P = 0.012)。两组的视觉效果相当。然而,包括Tenon囊肿在内的并发症在聚丙烯板组比硅酮板组更频繁地观察到(P<0.05)。

结论

与聚丙烯(型号S2)植入物相比,硅酮Ahmed青光眼阀(型号FP7)显示出更好的眼压降低效果。在平均眼压、成功率和并发症方面观察到的差异表明板材料可能影响临床结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验